Monkman S C, Armstrong R, Flanagan R J, Holt D W, Rosevear S
Poisons Unit, Guy's Hospital, London, UK.
Biomed Chromatogr. 1989 Mar;3(2):88-91. doi: 10.1002/bmc.1130030211.
A method is described for the measurement of lignocaine in small samples of fetal and placental tissue. Tissue samples (ca 100 mg) are digested using a preteolytic enzyme. Lignocaine and an internal standard are extracted into methyl tert-butyl ether and analysed by high-performance liquid chromatography with electrochemical detection (+1.0 V vs Ag/AgCl). The limit of accurate measurement is better than 0.1 mg/kg wet weight for a 100 mg sample. This method has been used to assess fetal exposure to the drug when used as a local anaesthetic during transabdominal placental biopsy (chorionic villus sampling). The range of lignocaine concentrations found in the tissue samples was large (from less than 0.04 mg/kg wet weight to 15.4 mg/kg wet weight) although most samples contained less than 1.0 mg lignocaine/kg wet weight.
本文描述了一种用于测量胎儿和胎盘组织小样本中利多卡因的方法。组织样本(约100毫克)用蛋白水解酶消化。利多卡因和内标物被萃取到甲基叔丁基醚中,并通过带有电化学检测(相对于Ag/AgCl为+1.0 V)的高效液相色谱法进行分析。对于100毫克的样本,准确测量的限度优于0.1毫克/千克湿重。当该药物在经腹胎盘活检(绒毛取样)期间用作局部麻醉剂时,此方法已用于评估胎儿对该药物的暴露情况。尽管大多数样本中利多卡因含量低于1.0毫克/千克湿重,但在组织样本中发现的利多卡因浓度范围很大(从低于0.04毫克/千克湿重到15.4毫克/千克湿重)。